查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595154

POC 血脂測試市場：按成分、適應症和最終用戶分類 - 2025-2030 年全球預測

POC Lipid Testing Market by Component (Instruments, Software), Indication (Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年POC血脂檢測市值為3.1541億美元，預計到2024年將達到3.3333億美元，複合年成長率為6.18%，到2030年將達到4.8015億美元。

POC（照護現場）血脂檢測是更廣泛的診斷環境中的一個新領域，重點是在傳統實驗室（例如診所和家庭環境）之外提供即時血脂分析。這種快速檢測模式滿足了早期檢測需要持續監測血脂水平的疾病（例如心血管疾病和糖尿病）的迫切需求。 POC 血脂檢測的效用在於其能夠提供快速、可靠的結果，使醫療保健提供者能夠及時做出決策並個性化患者護理。快速的都市化和不斷提高的醫療意識正在推動從臨床實驗室到居家醫療等各種環境的需求，大大擴大了最終用途的範圍。關鍵的成長要素包括慢性病的增加、可攜式檢測設備的技術進步以及消費者對快速便捷診斷的偏好。然而，市場面臨可能影響更廣泛採用的限制，包括監管挑戰、成本限制和準確性問題。儘管存在這些障礙，奈米技術和生物感測器的最新進展為創新提供了肥沃的土壤，並透過提供提高精度和降低成本的機會來擴大市場範圍。公司可以透過投資專注於下一代 POC 設備的研發並促進與醫療保健提供者的合作來抓住這些機會，以教育患者了解 POC 測試的好處。市場競爭激烈，多家公司力爭透過產品線多元化和創新來贏得市場佔有率。隨著市場的發展，整合人工智慧和資料分析以增強預測診斷可能成為關鍵的差異化因素。總之，儘管存在挑戰，但對技術進步、監管合規性和戰略夥伴關係關係的關注將使 POC 脂質檢測市場持續成長，使其成為探索和創新的成熟領域。

主要市場統計
基準年[2023] 31541萬美元
預測年份 [2024] 33333萬美元
預測年份 [2030] 48015萬美元
複合年成長率（%） 6.18%

市場動態：揭示快速發展的 POC 脂質測試市場的關鍵市場洞察

POC 血脂檢測市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球心血管疾病盛行率不斷上升
    • 增加私營和公共部門對醫療保健的投資
  • 市場限制因素
    • 製造 POC 血脂檢測產品的高成本
  • 市場機會
    • 醫療產業照護現場血脂檢測產品開發的持續創新
    • 透過增加診斷中心來改善獲得醫療保健和檢測的機會
  • 市場問題
    • 與 POC 血脂檢測相關的品質問題

波特五力：駕馭 POC 血脂檢測市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解 POC 脂質檢測市場的外部影響

外部宏觀環境因素在塑造 POC 血脂檢測市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解POC血脂檢測市場競爭格局

對 POC 血脂檢測市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣：POC血脂檢測市場供應商績效評估

FPNV定位矩陣是評估POC血脂檢測市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製 POC 血脂檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對 POC 血脂檢測市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心血管疾病盛行率增加
      • 增加私營和公共部門對醫療保健的投資
    • 抑制因素
      • 製造 POC 血脂檢測產品的高成本
    • 機會
      • 持續創新醫療產業照護現場血脂檢測產品的開發
      • 透過增加診斷中心來改善獲得醫療保健和檢測的機會
    • 任務
      • 與 POC 血脂檢測相關的品質問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 POC 脂質檢測市場：依組成部分

  • 介紹
  • 裝置
  • 軟體

第7章 POC 血脂檢測市場：依適應症分類

  • 介紹
  • 心血管疾病
  • 高膽固醇症
  • 高血脂症
  • 丹吉爾病

第8章 POC 脂質測試市場：依最終用戶分類

  • 介紹
  • 診斷中心
  • 醫院/診所

第9章 美洲POC血脂檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太POC血脂檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲POC血脂檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abaxis, Inc. by Zoetis Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Callegari Srl
  • Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • General Life BIoTechnology Co., Ltd.
  • Helena Laboratories Corporation
  • Menarini Group
  • Nova Biomedical
  • Quidel Corporation
  • SD Biosensor, Inc.
  • Sekisui Medical Co., Ltd.
  • Siemens AG
  • Sienco, Inc.
  • Sinocare Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity BIoTech PLC
  • VivaChek BIoTech（Hangzhou）Co., Ltd.
  • Werfen, SA
Product Code: MRR-DD0700E81D15

The POC Lipid Testing Market was valued at USD 315.41 million in 2023, expected to reach USD 333.33 million in 2024, and is projected to grow at a CAGR of 6.18%, to USD 480.15 million by 2030.

Point-of-Care (POC) Lipid Testing is an emerging segment within the broader diagnostics landscape, focused on providing immediate lipid profile analysis outside traditional laboratory settings, such as clinics and home environments. This rapid testing paradigm serves the critical need for early detection of conditions like cardiovascular diseases and diabetes, which require continual monitoring of lipid levels. The utility of POC lipid testing lies in its ability to offer swift, reliable results, enabling healthcare providers to make timely decisions and personalize patient care. Rapid urbanization and rising healthcare awareness are propelling demands across varied settings, from clinical laboratories to home healthcare, extending the end-use scope significantly. Key growth influencers include increasing incidences of chronic diseases, technological advancements in portable testing devices, and consumer preference for quick, convenient diagnostics. However, the market faces limitations like regulatory challenges, cost constraints, and issues concerning accuracy that could impact wider adoption. Despite these hurdles, recent advances in nanotechnology and biosensors present fertile ground for innovation, offering opportunities to enhance accuracy and reduce costs, thus expanding market reach. Companies can capture these opportunities by investing in R&D focused on next-generation POC devices and fostering collaborations with healthcare providers to educate patients about the benefits of POC testing. The nature of the market is competitive, with several players striving for market share through diversification and innovation in product lines. As the market evolves, integrating artificial intelligence and data analytics to enhance predictive diagnostics can be key differentiators. In summary, while challenges exist, focusing on technological advancements, regulatory compliance, and strategic partnerships can enable sustained growth in the POC lipid testing market, making it an area ripe for exploration and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 315.41 million
Estimated Year [2024] USD 333.33 million
Forecast Year [2030] USD 480.15 million
CAGR (%) 6.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving POC Lipid Testing Market

The POC Lipid Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in prevalence of cardiovascular disease across the globe
    • Rising investment on healthcare by private and public sector
  • Market Restraints
    • High cost associated with the production of POC lipid testing products
  • Market Opportunities
    • Ongoing innovation in medical industry for developing point of care lipid test products
    • Improving accessibility to healthcare and tests with rise in number of diagnostic centers
  • Market Challenges
    • Quality concerns associated with POC lipid testing

Porter's Five Forces: A Strategic Tool for Navigating the POC Lipid Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the POC Lipid Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the POC Lipid Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the POC Lipid Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the POC Lipid Testing Market

A detailed market share analysis in the POC Lipid Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the POC Lipid Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the POC Lipid Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the POC Lipid Testing Market

A strategic analysis of the POC Lipid Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the POC Lipid Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc. by Zoetis Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Callegari Srl, Chembio Diagnostic Systems, Inc. by BIOSYNEX SA, Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., General Life Biotechnology Co., Ltd., Helena Laboratories Corporation, Menarini Group, Nova Biomedical, Quidel Corporation, SD Biosensor, Inc., Sekisui Medical Co., Ltd., Siemens AG, Sienco, Inc., Sinocare Inc., Thermo Fisher Scientific Inc., Trinity Biotech PLC, VivaChek Biotech (Hangzhou) Co., Ltd., and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the POC Lipid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Instruments and Software.
  • Based on Indication, market is studied across Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia, and Tangier Disease.
  • Based on End-User, market is studied across Diagnostic Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of cardiovascular disease across the globe
      • 5.1.1.2. Rising investment on healthcare by private and public sector
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the production of POC lipid testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovation in medical industry for developing point of care lipid test products
      • 5.1.3.2. Improving accessibility to healthcare and tests with rise in number of diagnostic centers
    • 5.1.4. Challenges
      • 5.1.4.1. Quality concerns associated with POC lipid testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. POC Lipid Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Software

7. POC Lipid Testing Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Hypercholesterolemia
  • 7.4. Hyperlipidaemia
  • 7.5. Tangier Disease

8. POC Lipid Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals & Clinics

9. Americas POC Lipid Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific POC Lipid Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa POC Lipid Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abaxis, Inc. by Zoetis Inc.
  • 2. Abbott Laboratories
  • 3. Bio-Rad Laboratories, Inc.
  • 4. bioMerieux SA
  • 5. Callegari Srl
  • 6. Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
  • 7. Danaher Corporation
  • 8. EKF Diagnostics Holdings plc
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. General Life Biotechnology Co., Ltd.
  • 11. Helena Laboratories Corporation
  • 12. Menarini Group
  • 13. Nova Biomedical
  • 14. Quidel Corporation
  • 15. SD Biosensor, Inc.
  • 16. Sekisui Medical Co., Ltd.
  • 17. Siemens AG
  • 18. Sienco, Inc.
  • 19. Sinocare Inc.
  • 20. Thermo Fisher Scientific Inc.
  • 21. Trinity Biotech PLC
  • 22. VivaChek Biotech (Hangzhou) Co., Ltd.
  • 23. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. POC LIPID TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. POC LIPID TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POC LIPID TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POC LIPID TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POC LIPID TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POC LIPID TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POC LIPID TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POC LIPID TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POC LIPID TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POC LIPID TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POC LIPID TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POC LIPID TESTING MARKET SIZE, BY HYPERCHOLESTEROLEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POC LIPID TESTING MARKET SIZE, BY HYPERLIPIDAEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POC LIPID TESTING MARKET SIZE, BY TANGIER DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POC LIPID TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POC LIPID TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2023